This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

RCT on Ketorolac and Tramadol in Bone Fractures Pain of Child

This study has been completed.
Information provided by (Responsible Party):
IRCCS Burlo Garofolo Identifier:
First received: November 7, 2007
Last updated: August 23, 2017
Last verified: August 2017

Randomized double blind Trial with the aim to estimate effectiveness of two therapeutic regimes per os on pain due to not compound bone fractures in child 4-17 years old:

  • ketorolac 0,5 mg/kg (1 drop every 2 Kg)
  • tramadol 2,5 mg/Kh (1 drop every 2 Kg)

Intensity of pain will be estimated with linear 1 to 10 or analogic McGrath type scale every 20 min.

The main objectives are the evaluation of pain decreasing in every group, the time of decreasing, the intensity of pain during procedures (ex. Xray) and the occurrence of side effects Secondary outcomes are comparison between the two groups on effectiveness on pain and on side effects

Condition Intervention Phase
Fracture Pain Drug: ketorolac Drug: tramadol Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Randomized Controlled Trial on Effectiveness of Ketorolac and Tramadol in Not Compound Fractures of Child

Resource links provided by NLM:

Further study details as provided by IRCCS Burlo Garofolo:

Primary Outcome Measures:
  • estimation of pain reduction in every arm of the trial with linear 1-10 pain scale or for children 4 - 6 years old with analogic MacGrath type scale [ Time Frame: 6 hours (or until the end of procedures) ]

Secondary Outcome Measures:
  • comparison between the two groups on effectiveness on pain, measured with linear and analogic scale (see above) [ Time Frame: 6 hours or until the end of procedures ]

Enrollment: 133
Actual Study Start Date: February 2008
Study Completion Date: April 2012
Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: 1
children 4-17 y. old with not compound bone fracture treated with ketorolac
Drug: ketorolac
0,5 mg/kg per os one time
Experimental: 2
children 4-17 y. old with not compound bone fracture treated with tramadol
Drug: tramadol
2,5 mg/ kg per os in one dose


Ages Eligible for Study:   4 Years to 17 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Children 4-17 years old with not compound bone fracture presenting in emergency room

Exclusion Criteria:

  • Compound fracture
  • Occurring pain still treated
  • Contraindicated ketorolac or tramadol use
  • Informed consensus not obtained
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00560443

IRCCS Burlo Garofolo
Trieste, Italy, 34100
Sponsors and Collaborators
IRCCS Burlo Garofolo
Principal Investigator: Edoardo Guglia, md IRCCS Burlo Garofolo
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: IRCCS Burlo Garofolo Identifier: NCT00560443     History of Changes
Other Study ID Numbers: RC 30/07
Study First Received: November 7, 2007
Last Updated: August 23, 2017

Keywords provided by IRCCS Burlo Garofolo:
bone fracture

Additional relevant MeSH terms:
Fractures, Bone
Wounds and Injuries
Ketorolac Tromethamine
Analgesics, Opioid
Central Nervous System Depressants
Physiological Effects of Drugs
Sensory System Agents
Peripheral Nervous System Agents
Anti-Inflammatory Agents, Non-Steroidal
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Antirheumatic Agents
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action processed this record on September 21, 2017